Bone Growth Stimulators Market Size, Share, Growth Analysis, By Application(Spinal Fusion, Maxillofacial & Dental), By End User(Hospitals & ASCs, Specialty Clinics) - Industry Forecast 2024-2031

Global Bone Growth Stimulators Market size was valued at USD 1.93 billion in 2022 and is poised to grow from USD 2.02 billion in 2023 to USD 2.97 billion by 2031, at a CAGR of 4.9% during the forecast period (2024-2031).

Bone growth stimulation, a complementary therapy, has gained popularity, particularly for bone mending. For fractures that have not recovered on their own, bone stimulators are frequently employed. The number of bone fractures and sports-related injuries is gradually rising, which is driving up demand for bone growth stimulators all around the world. According to the National Spinal Cord Injury Statistical Centre (NSCISC), there are about 54 cases of spinal cord injury (SCI) per million people in the United States per year. Around the world, 250,000 to 500,000 persons get spinal cord injuries annually, according to a recent report from the National Centre for Biotechnology Information. Orthopaedic surgeries have benefited from bone growth stimulating technology and products. Numerous clinical research on bone morphogenetic protein has been started because of the market potential. These simulators are used extensively in many different fields, including spinal fusion, dentistry, maxillofacial, fracture repair, and many more. The market is expanding as a result of the increasing incidence of osteoarthritis and degenerative bone diseases. Additionally, due to the quick uptake and demand for platelet-rich plasma and bone morphogenetic proteins market growth is also anticipated to be aided by improved healing outcomes.